LUMOS PHARMA, INC Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementLumos Pharma, Inc. • December 30th, 2020 • Pharmaceutical preparations • New York
Lumos Pharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
